Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Bevasizumab in the Management of Acute Radiation-induced and Chemotherapy-induced Pulmonary Fibrosis

NCT01917877 is registered in ClinicalTrials.gov with Qingdao Central Hospital as lead sponsor.

NCT NCT01917877
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01917877 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Bevasizumab in the Management of Acute Radiation-induced and Chemotherapy-induced Pulmonary Fibrosis
Lead sponsor
Qingdao Central Hospital
Phase
Phase 2
Overall status
Unknown status
Start date
August 1, 2013
Completion date
December 30, 2025
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary fibrosis